109 related articles for article (PubMed ID: 18709678)
1. Intact presupplementary motor area function in early, untreated Parkinson's disease.
Martin WR; Wieler M; Gee M; Hanstock CC; Camicioli RM
Mov Disord; 2008 Sep; 23(12):1756-9. PubMed ID: 18709678
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease.
Camicioli RM; Hanstock CC; Bouchard TP; Gee M; Fisher NJ; Martin WR
Mov Disord; 2007 Feb; 22(3):382-6. PubMed ID: 17216652
[TBL] [Abstract][Full Text] [Related]
3. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in Kennedy disease.
Lee CH; Lai PH; Liu CS; Li JY
J Neurol Sci; 2009 Feb; 277(1-2):71-5. PubMed ID: 19019384
[TBL] [Abstract][Full Text] [Related]
6. Motor cortex reorganisation in Parkinson's disease.
Thickbroom GW; Byrnes ML; Walters S; Stell R; Mastaglia FL
J Clin Neurosci; 2006 Jul; 13(6):639-42. PubMed ID: 16814549
[TBL] [Abstract][Full Text] [Related]
7. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease.
Hamada M; Ugawa Y; Tsuji S;
Mov Disord; 2008 Aug; 23(11):1524-31. PubMed ID: 18548577
[TBL] [Abstract][Full Text] [Related]
8. Reduced brain glutamate in patients with Parkinson's disease.
Griffith HR; Okonkwo OC; O'Brien T; Hollander JA
NMR Biomed; 2008 May; 21(4):381-7. PubMed ID: 17907264
[TBL] [Abstract][Full Text] [Related]
9. [Motor association cortex activity in Parkinson's disease--a functional MRI study].
Tada Y
Rinsho Shinkeigaku; 1998 Aug; 38(8):729-35. PubMed ID: 9916518
[TBL] [Abstract][Full Text] [Related]
10. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.
MacDonald V; Halliday GM
Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053
[TBL] [Abstract][Full Text] [Related]
11. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
13. Improvement after cerebrospinal fluid drainage is related to levels of N-acetyl-aspartate in idiopathic normal pressure hydrocephalus.
Lenfeldt N; Hauksson J; Birgander R; Eklund A; Malm J
Neurosurgery; 2008 Jan; 62(1):135-41, discussion 141-2. PubMed ID: 18300900
[TBL] [Abstract][Full Text] [Related]
14. Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.
Lewis SJ; Shine JM; Duffy S; Halliday G; Naismith SL
Mov Disord; 2012 Sep; 27(10):1262-7. PubMed ID: 22865474
[TBL] [Abstract][Full Text] [Related]
15. Patterns of cortical thickness and surface area in early Parkinson's disease.
Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O
Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830
[TBL] [Abstract][Full Text] [Related]
16. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
Kaymak SU; Demir B; Oğuz KK; Sentürk S; Uluğ B
Psychiatry Clin Neurosci; 2009 Jun; 63(3):350-6. PubMed ID: 19566767
[TBL] [Abstract][Full Text] [Related]
19. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
20. Brain N-acetylaspartate is reduced in Parkinson disease with dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimer Dis Assoc Disord; 2008; 22(1):54-60. PubMed ID: 18317247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
